Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

NCT04282109

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario Donostia- Donostia Unibertsitate Ospitalea San Sebastián, San Sebastían, Spain
  • Centro Oncoloxico de Galicia A Coruña, Spain
  • Hospital Universitari Germans Trias i Pujol de Badalona Badalona, Spain
View all 21 locations
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

NCT04489888

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0265) New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center & Research Institute ( Site 0214) Newark, Delaware, United States
  • Baptist MD Anderson Cancer Center ( Site 0215) Jacksonville, Florida, United States
  • Orlando Health, Inc. ( Site 0216) Orlando, Florida, United States
View all 35 locations
View Trial Details
Completed

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +16 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions